Roger Barker, PhD
Affiliations: | 1992- | Brain Repair Centre | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"Roger Barker"Mean distance: 15.67 (cluster 6) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Barker RA, Björklund A, Parmar M. (2024) The history and status of dopamine cell therapies for Parkinson's disease. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. e2400118 |
| Braun E, Danan-Gotthold M, Borm LE, et al. (2023) Comprehensive cell atlas of the first-trimester developing human brain. Science (New York, N.Y.). 382: eadf1226 |
| Bulstrode H, Girdler GC, Gracia T, et al. (2022) Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells. Neuron |
| Kaiser K, Jang A, Kompanikova P, et al. (2022) Correction: MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. Development (Cambridge, England). 149 |
| Qarin S, Howlett SK, Jones JL, et al. (2021) The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease. Neuronal Signaling. 5: NS20200083 |
| Griffiths WJ, Abdel-Khalik J, Moore SF, et al. (2021) The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson's Disease and Their Association With Disease State and Clinical Features. Frontiers in Aging Neuroscience. 13: 685594 |
| Barker RA, Björklund A, Frucht SJ, et al. (2021) Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease? Journal of Parkinson's Disease. 11: 909-917 |
| Kaiser K, Jang A, Kompanikova P, et al. (2021) MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. Development (Cambridge, England). 148 |
| Barbuti PA, Barker RA, Brundin P, et al. (2021) Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Yoon Y, Kim HS, Jeon I, et al. (2020) Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. Stem Cells (Dayton, Ohio) |